This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Cuántos subordinados directos
Neilson, Gary L.; Wulf, Julie M.Article HBS-R1204HKnowledge and CommunicationSi los altos ejecutivos se sienten cada vez más presionados por el tiempo, por qué iban a agregar más a sus platos? Puede sonar contradictorio, pero la investigación de Booz & Company Gary L. Neilson y Harvard Business School profesor Julie Wulf muestra que en los últimos 20 años esperanza media del CEO de control, medida por el número de informes directos, se ha duplicado. Se encuentra en casi el 10 por hoy. Esto le da relevancia fresca a una pr...Starting at €8.20
-
Alibaba Group (Spanish version)
Wulf, Julie M.Case HBS-710S18StrategyDiscusses how Alibaba Group successfully managed new business ventures to become a leader in China's online marketplaces. Students follow Alibaba Group's transition from a startup to a multibusiness firm with over 15,000 employees in just over a decade. They analyze the evolving dynamics of internal competition and cooperation among Alibaba Group's subsidiaries. Students are also asked to address Alibaba Group's strategy, the role of its corporat...Starting at €8.20
-
Organization and Strategy at Millennium (A)
Wulf, Julie M.; Waggoner, ScottCase HBS-710415-ELeadership and People ManagementThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to ju...Starting at €8.20
-
Organization and Strategy at Millennium (B)
Wulf, Julie M.; Waggoner, ScottCase HBS-710418-EStrategyThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to just t...Starting at €5.74
-
How Many Direct Reports
Neilson, Gary L.; Wulf, Julie M.Article HBS-R1204H-EIf senior executives are feeling ever more pressed for time, why would they add more to their plates? It might sound counterintuitive, but research by Booz & Company's Gary L. Neilson and Harvard Business School professor Julie Wulf shows that over the past 20 years the CEO's average span of control, measured by the number of direct reports, has doubled. It stands at almost 10 today. This gives fresh relevance to a perennial question for senior l...Starting at €8.20
-
TravelCenters of America
Greenwood, Robin; Goldberg, Daniel; Quinn, JamesCase HBS-209030-EFinanceA New York-based hedge fund must decide whether to invest in TravelCenters of America (TA), a recent spin-off from a U.S.-based real estate investment trust. The case confronts students with the question: To what extent is this spin-off opportunity attractive from a value-investing standpoint? Historically, spin-offs have been attractive investments because of supply-demand dynamics associated with their investor base. The case is an opportunity ...Starting at €8.20
-
Citigroup's Exchange Offer (C)
Greenwood, Robin; Quinn, JamesCase HBS-210015-EFinanceCitigroup faced considerable distress in early 2009. In late 2008, the bank had accepted $45 billion in preferred equity from the United States government via the Troubled Assets Relief Program (TARP). Yet, the stock had continued to slide in early 2009. In late February, the company announced that it would convert as much as $50 billion of preferred stock into common stock, at $3.25 per share. The case asks students to evaluate the pricing of pr...Starting at €5.74
-
Parity Conditions and Cross-Border Valuation (Brief Case) (Spanish version)
Luehrman, Timothy A.; Quinn, JamesCase HBS-411S20FinanceProject Evaluation, Cross-Border, Capital Budgeting, Net Present Value, Foreign Exchange, Securities Analysis, Parity Condition, DCF Valuation, and Exchange Rate.Starting at €8.20
-
Citigroup's Exchange Offer (B)
Greenwood, Robin; Quinn, JamesCase HBS-210004-EFinanceCitigroup faced considerable distress in early 2009. In late 2008, the bank had accepted $45 billion in preferred equity from the United States government via the Troubled Assets Relief Program (TARP). Yet, the stock had continued to slide in early 2009. In late February, the company announced that it would convert as much as $50 billion of preferred stock into common stock, at $3.25 per share. The case asks students to evaluate the pricing of pr...Starting at €5.74
-
Citigroup's Exchange Offer
Greenwood, Robin; Quinn, JamesCase HBS-210009-EFinanceCitigroup faced considerable distress in early 2009. In late 2008, the bank had accepted $45 billion in preferred equity from the United States government via the Troubled Assets Relief Program (TARP). Yet, the stock had continued to slide in early 2009. In late February, the company announced that it would convert as much as $50 billion of preferred stock into common stock, at $3.25 per share. The case asks students to evaluate the pricing of pr...Starting at €8.20